Proteinuria: all 328 studies

Page 1 of 4. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.

• A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A NephropathyRecruitingNCT07902817Phase 3
• A Study of the Efficacy and Safety of Zigakibart + Atrasentan in Adult Patients With Primary IgA NephropathyNot yet recruitingNCT07850752Phase 3
• Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA NephropathyNot yet recruitingNCT07785128Phase 2
• A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA NephropathyNot yet recruitingNCT07642050Phase 3
• A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) GuidelinesRecruitingNCT07561957Not applicable
• A Study of JADE101 in Participants With Immunoglobulin A NephropathyRecruitingNCT07541287Phase 2
• Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe ProteinuriaNot yet recruitingNCT07431931Not applicable
• A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 GlomerulopathyRecruitingNCT07416162
• Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer PatientsNot yet recruitingNCT07358520Phase 4
• Huaier Granule and ProteinuriaNot yet recruitingNCT07355361Phase 2
• CHART-C3G/CLNP023B12011Not yet recruitingNCT07331259
• A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)RecruitingNCT07268638Phase 2
• Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney DiseaseRecruitingNCT07260071
• Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated ProteinuriaRecruitingNCT07224776Phase 1
• SGLT2 Inhibitors in Adult Primary Nephrotic SyndromeRecruitingNCT07214818Phase 2/3
• A Study to Assess the Effects of Zigakibart on IgA Nephropathy.RecruitingNCT07146906Phase 2
• Study of BHV-1400 in IgA NephropathyRecruitingNCT07054684Phase 1
• Nefecon and Ambrisentan in IgA NephropathyRecruitingNCT07030894Phase 4
• Study of Ravulizumab in Pediatric Participants With Primary IgANRecruitingNCT07024563Phase 3
• Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgANRecruitingNCT06994845Phase 3
• Beneficial Effect of Amiloride on Progression of Chronic Kidney DiseaseRecruitingNCT06923709Phase 2
• The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in ChildrenRecruitingNCT06890143Phase 3
• Effect Camostat for Kidney Protection in Chronic Kidney DiseaseRecruitingNCT06794593Phase 2
• Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics StudyNot yet recruitingNCT06792448
• An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte DiseasesRecruitingNCT06664814Phase 2
• Efficacy of On-venous Laser Irradiation of Blood on Diabetes Kidney Disease PatientsEnrolling by invitationNCT06588465Not applicable
• Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus LosartanNot yet recruitingNCT06491940Not applicable
• Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN StudyRecruitingNCT06350630Phase 2
• ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and BiobankRecruitingNCT06162546
• Empagliflozin Treatment in Kidney Transplant RecipientsRecruitingNCT06013865Phase 4
• Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.Not yet recruitingNCT05966818Phase 4
• Role of Vitamin K2 in Chronic Kidney DiseaseRecruitingNCT05942053Phase 4
• Role of Coenzyme Q10 in Chronic Kidney DiseaseRecruitingNCT05942027Phase 4
• Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGNRecruitingNCT05755386Phase 3
• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and ProteinuriaRecruitingNCT05457283Phase 3
• Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.RecruitingNCT04817618Phase 3
• Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)RecruitingNCT04752293
• A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe ProteinuriaRecruitingNCT04456816Phase 2
• Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study)RecruitingNCT02818192
• EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIVEnrolling by invitationNCT02699736
• Proteinuria in Pre and Post TransplantRecruitingNCT01094327
• Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal CenterEnrolling by invitationNCT01016613
• Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyRecruitingNCT00977977Phase 2
• Urinary Vitamin C Loss in Diabetic SubjectsRecruitingNCT00071526
• Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With AlbuminuriaCompletedNCT06150924Phase 2Results posted
• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy PatientsCompletedNCT04578834Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney DiseaseTerminatedNCT04492722Phase 2Results posted
• Safety and Efficacy Study of VIS649 for IgA NephropathyCompletedNCT04287985Phase 2Results posted
• Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney InjuryTerminatedNCT04051957Phase 2Results posted
• Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA NephropathyTerminatedNCT04042623Phase 2Results posted
• A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic SyndromeTerminatedNCT03703908Phase 2Results posted
• Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) NephropathyTerminatedNCT03608033Phase 3Results posted
• Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry DiseaseCompletedNCT03566017Phase 3Results posted
• A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)TerminatedNCT03448692Phase 2Results posted
• Effects of Dapagliflozin in Non-diabetic Patients With ProteinuriaCompletedNCT03190694Phase 2Results posted
• Adrenocorticotropic Hormone in Membranous NephropathyCompletedNCT03025828Phase 4Results posted
• Efficacy and Safety of Atacicept in IgA NephropathyTerminatedNCT02808429Phase 2Results posted
• Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal FunctionCompletedNCT02795676Phase 3Results posted
• Preventing Sickle Cell Kidney DiseaseTerminatedNCT02373241Phase 2Results posted
• Belatacept Conversion in Proteinuric Kidney Transplant RecipientsCompletedNCT02327403Phase 2Results posted
• Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of ProgressionCompletedNCT02282930Phase 3Results posted
• Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant RecipientsTerminatedNCT02057523Phase 4Results posted
• Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23CompletedNCT02020785Not applicableResults posted
• Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and AlbuminuriaCompletedNCT02010242Phase 2Results posted
• Acthar for Treatment of Proteinuria in Diabetic Nephropathy PatientsCompletedNCT01601236Phase 2Results posted
• A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGSCompletedNCT01573533Phase 2Results posted
• Acthar for Treatment of Proteinuria in Membranous Nephropathy PatientsCompletedNCT01386554Phase 4Results posted
• Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic PatientsCompletedNCT01382303Phase 4Results posted
• Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous NephropathyCompletedNCT01282073Phase 3Results posted
• N-Acetylcysteine and Milk Thistle for Treatment of Diabetic NephropathyCompletedNCT01265563Phase 2Results posted
• Rituximab to Prevent Recurrence of ProteinuriaTerminatedNCT01164098Phase 3Results posted
• Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)CompletedNCT01129284Phase 4Results posted
• Oral Galactose in Children With Steroid Resistant Nephrotic SyndromeCompletedNCT01113385Not applicableResults posted
• Pilot Study of Velcade® in IgA NephropathyCompletedNCT01103778Phase 4Results posted
• Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced ProteinuriaCompletedNCT01044771Not applicableResults posted
• The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney DiseaseCompletedNCT01029002Phase 3Results posted
• A Prospective Study of Microalbuminuria in Untreated Boys With Alport SyndromeCompletedNCT00622544Results posted
• Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal FunctionTerminatedNCT00586261Not applicableResults posted
• An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))CompletedNCT00568178Phase 3Results posted
• Rituximab in Progressive Immunoglobulin A (IgA) NephropathyCompletedNCT00498368Phase 4Results posted
• Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic NephropathyCompletedNCT00324675Not applicableResults posted
• Mycophenolate Mofetil (MMF) in Patients With IgA NephropathyTerminatedNCT00318474Phase 3Results posted
• Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal DiseaseCompletedNCT00296400Phase 2Results posted
• Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal DiseaseCompletedNCT00296374Phase 2Results posted
• ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy TrialCompletedNCT00141453Phase 3Results posted
• Podocyte RetinoidsCompletedNCT00098020Phase 2Results posted
• Angiotensin II Blockade for Chronic Allograft NephropathyCompletedNCT00067990Phase 4Results posted
• Steroid Treatment for Kidney DiseaseCompletedNCT00065611Phase 3Results posted
• Permeability Factor in Focal Segmental GlomerulosclerosisCompletedNCT00007475Phase 1/2Results posted
• Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)CompletedNCT00001959Phase 2Results posted
• Body Composition, Urine Protein, and Kidney Blood Flow After Nutritional Counseling in Children With Nutcracker SyndromeCompletedNCT07868406
• Serum and Urinary sCD163 in IgA NephropathyCompletedNCT07754019
• Proteinuria in Normotensive Diabetic Patients: ARBs Alone or in Combination of SGLT2iActive, not recruitingNCT07586371Phase 2/3
• FINEPKT - Finerenone in Proteinuria Patients After Kidney TransplanActive, not recruitingNCT07356388Phase 3
• KPs Supplement for Inflammation, Oxidative Stress and Lipid Abnormalities in CKD Patients.CompletedNCT07260292Not applicable
• Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental GlomerulosclerosisActive, not recruitingNCT07219121Phase 4
• Efficacy and Safety of Dapagliflozin in Children With ProteinuriaActive, not recruitingNCT07204743Not applicable
• Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Progressive Chronic Kidney DiseaseCompletedNCT07150338
• Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy PatientsWithdrawnNCT07022574Not applicable
• Role of QRX-3 in Chronic Kidney Disease Patients in Outpatients ClinicsCompletedNCT06948292Phase 2

← Proteinuria overview